Sponsor content
184 result(s) found, displaying 61 to 70
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METFORMIN-MA XR 500 metformin hydrochloride 500 mg extended release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METFORMIN-ME XR 1000 metformin hydrochloride 1000 mg extended release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METFORMIN-MH XR 1000 metformin hydrochloride 1000 mg extended release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METFORMIN-MH XR 500 metformin hydrochloride 500 mg extended release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METFORMIN-MC XR 1000 metformin hydrochloride 1000 mg extended release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METFORMIN-MC XR 500 metformin hydrochloride 500 mg extended release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METFORMIN-MA XR 1000 metformin hydrochloride 1000 mg extended release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MEDREICH METFORMIN XR 500 metformin hydrochloride 500 mg extended release tablet blister pack.
-
Prescription medicine registrationActive ingredients: ticagrelor.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2025